about
Effect of topiramate on acid-base balance: extent, mechanism and effectsSerotonin 1B autoreceptors originating in the caudal dorsal raphe nucleus reduce expression of fear and depression-like behavior.Translational imaging studies of cortical spreading depression in experimental models for migraine aura.Clinical pharmacology of topiramate in migraine prevention.Topiramate modulates habituation in migraine: evidences from nociceptive responses elicited by laser evoked potentialsTopiramate and the vision: a systematic review.Developing master keys to brain pathology, cancer and aging from the structural biology of proteins controlling reactive oxygen species and DNA repair.Patient outcome in migraine prophylaxis: the role of psychopharmacological agentsNew acute treatments for headache.New frontiers in headache therapy.The therapeutic future in headache.The effect of sumatriptan on nitric oxide synthase enzyme production after iatrogenic inflammation in the brain stem of adolescent rats: A randomized, controlled, experimental studyThe triptans.Intrapulmonary and intravenous administrations of dihydroergotamine mesylate have similar cardiovascular effects in the conscious dog.Gellan gum-based mucoadhesive microspheres of almotriptan for nasal administration: Formulation optimization using factorial design, characterization, and in vitro evaluation.Metoclopramide versus sumatriptan for treatment of migraine headache: A randomized clinical trialThe abnormal recovery cycle of somatosensory evoked potential components in children with migraine can be reversed by topiramate.Optimization of combinations of ginsenoside-Rg1, ginsenoside-Rb1, evodiamine and rutaecarpine for effective therapy of mouse migraine.Bilateral acute angle closure glaucoma and myopic shift by topiramate-induced ciliochoroidal effusion: case report and literature review.The Biology of Monoclonal Antibodies: Focus on Calcitonin Gene-Related Peptide for Prophylactic Migraine Therapy.
P2860
Q24643009-FB0F4520-03E1-478C-9A7E-5716ED489348Q30468511-4E40930C-2B97-4A09-8A9E-AAED765EB03BQ31154455-008F5BD3-82DE-49F1-95EB-B5A4DC649464Q34200361-D8CED313-A1CA-4750-B2AB-1C286D0CA30BQ34659264-5E999A67-24EA-47DE-AFBA-ADBE8B879901Q35682062-7F659A8E-7012-4EC6-AC4A-76A0EF3B0C7FQ35865533-D8869791-2272-4490-B847-C518B5FEEBC9Q36160565-E7614F14-F232-426A-8B77-A2583615ADCCQ37750599-144509EE-6020-4016-BFCA-93EEDFCBEA09Q37870793-DA8402E4-4E46-49C6-9390-ACDCBE630DBAQ38014295-69DB74A4-7DAD-455D-BEF6-0A4F880B4DEBQ38536449-0953CF19-F912-4313-8AB1-16A0C82AC1BDQ39983756-E41C4215-5E5C-4C69-AD98-057BE4DBE85BQ40884660-50764186-9F3A-4A74-B0EA-72B320DFA226Q41964132-7FD4DB8B-60B0-4117-8A43-667D9E65CDACQ42776287-55F9F916-27EA-4442-8734-4885E50709FBQ45986094-58B06E9D-F170-460B-9C76-93C02588A6DEQ47350157-07C0B576-1FA8-463B-8C57-D8AB0399C09FQ48139297-979FE2AA-4A55-4AAD-BD8D-A8A72BBB806BQ52608146-2C57A7D9-BDE1-475B-A304-217F33B5E476
P2860
description
2006 nî lūn-bûn
@nan
2006 թուականի Յունիսին հրատարակուած գիտական յօդուած
@hyw
2006 թվականի հունիսին հրատարակված գիտական հոդված
@hy
2006年の論文
@ja
2006年論文
@yue
2006年論文
@zh-hant
2006年論文
@zh-hk
2006年論文
@zh-mo
2006年論文
@zh-tw
2006年论文
@wuu
name
New and future migraine therapy.
@ast
New and future migraine therapy.
@en
New and future migraine therapy.
@nl
type
label
New and future migraine therapy.
@ast
New and future migraine therapy.
@en
New and future migraine therapy.
@nl
prefLabel
New and future migraine therapy.
@ast
New and future migraine therapy.
@en
New and future migraine therapy.
@nl
P1476
New and future migraine therapy.
@en
P2093
Nabih M Ramadan
Thomas M Buchanan
P304
P356
10.1016/J.PHARMTHERA.2005.04.010
P577
2006-06-23T00:00:00Z